Adjuvant Chemotherapy for the Completely Resected Stage IB Nonsmall Cell Lung Cancer: A Systematic Review and Meta-Analysis

Adjuvant chemotherapy is recommended for postoperative stage II-IIIB nonsmall cell lung cancer patients. However, its effect remains controversial in stage IB patients. We, therefore, performed a meta-analysis to compare the efficacy of adjuvant chemotherapy versus surgery alone in stage IB patients...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Jiaxi, Shen, Jianfei, Yang, Chenglin, Jiang, Long, Liang, Wenhua, Shi, Xiaoshun, Xu, Xin, He, Jianxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
7100
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616365/
https://www.ncbi.nlm.nih.gov/pubmed/26039122
http://dx.doi.org/10.1097/MD.0000000000000903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616365/
https://www.ncbi.nlm.nih.gov/pubmed/26039122
http://dx.doi.org/10.1097/MD.0000000000000903

Ejemplares similares